DAFTAR REFERENSI CALPROTECTIN

1. Dhas DBB, Bhat BV, Gane DB. Role of calprotectin in infection and inflammation.
Curr Pediatr Res 2012;16(2):83-94.
2. Ramma W, Buhimschi IA, Zhao G, Dulay AT, Nayeri UA, Buhimschi CS, Ahmed A.
The elevation in circulating anti-angiogenic factors is independent of markers of
neutrophil activation in preeclampsia. Angiogenesis 2012 Sep;15(3):333-40.
Epub 2012 Mar 8.
3. Wynn JL, Levy O. Role of innate host defenses in susceptibility to early-onset
neonatal sepsis. Clin Perinatol. 2010 Jun;37(2):307-37.
4. Zegels G, Van Raemdonck GAA, Tjalma WAA, Van Ostade XWM. Use of
cervicovaginal fluid for the identification of biomarkers for pathologies of the
female genital tract. Proteome Sci. 2010;8:63.

5. Byum A, Skrede KK, Myhre O, Tennfjord VA, Neurauter CG, Tolleshaug H.

Calprotectin (S100A8/S100A9) and myeloperoxidase: co-regulators of formation
of reactive oxygen species. Toxins 2010; 2:95-115.
6. Hsu K, Champaiboon C, Guenther BD, Sorenson BS, Khammanivong A, Ross KF,
et al. Anti-infective protective properties of s100 calgranulins. Antiinflamm
Antiallergy Agents Med Chem. 2009;8(4):290305.
7. Urban CF, Ermert D, Schmid M, Abu-Abed U, Goosmann C, Nacken W, et al.

Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex

involved in host defense against Candida albicans. PLoS Pathog. 2009
Oct;5(10):e1000639. Epub 2009 Oct 30.
8. Bonrekci B, Aksoy H, Onztunrk N, Kadanali S. Correlation between
calprotectin and oxidized LDL in preeclampsia. Turk J Med Sci 2009; 39 (2): 1915.

9. Champaiboon

C, Sappington KJ, Guenther BD, Ross KF, Herzberg MC.

Calprotectin S100A9 calcium-binding loops I and II are essential for keratinocyte
resistance to bacterial invasion. J Biol Chem 2009 Mar; 284(11):7078-90.

10.Zali H, Rezaei-Tavirani M, Kariminia A, Yousefi R, Shokrgozar MA. Evaluation of

growth inhibitory and apoptosis inducing activity of human calprotectin on the
human gastric cell line (AGS). Iran Biomed J. 2008;12(1):7-14.
11.Yousefi R, Imani M, Ardestani SK, Saboury AA, Gheibi N, Ranjbar B. Human
calprotectin: effect of calcium and zinc on its secondary and tertiary structures,
and role of ph in its thermal stability. Acta Biochim Biophys Sin 2007; 39(10):
795-802.
12.Montgomery RR, Schreck K, Wang X, Malawista. SE Human neutrophil
calprotectin reduces the susceptibility of Borrelia burgdorferi to penicillin. Infect
Immun. 2006 Apr; 74(4): 2468-72.
13.Holthe MR, Staff AC, Berge LN, Fagerhol MK, Lyberg T. Calprotectin plasma level
is elevated in preeclampsia. Act Obst Gyn Scand 2005;84(2):151-4.

14.Braekke K , Holthe MR , Harsem N , Fagerhol MK , Staff AC. Calprotectin, a

marker of inflammation, is elevated in the maternal but not in the fetal
circulation in preeclampsia. Am J Obstet Gynecol. 2005 Jul;193(1):227-33.
15.Buhimschi IA, Buhimschi CS, Weiner CP, Kimura T, Hamar BD, Sfakianaki AK, et
al. Proteomic but not enzyme-linked immunosorbent assay technology detects
amniotic fluid monomeric calgranulins from their complexed calprotectin form.
Clin Diagn Lab Immunol. 2005 Jul;12(7):837-44.
16.Stroncek DF, Shankar RA, Skubitz KM. The subcellular distribution of myeloidrelated protein 8 (MRP8) and MRP14 in human neutrophils. J Transl Med.
2005;3:36.
17.Yousefi R, Ardestani SK, Saboury AA, Kariminia A, Zeinali
M, Amani M.
Investigation on the surface hydrophobicity and aggregation kinetics of human
calprotectin in the presence of calcium. J Biochem Mol Biol. 2005 Jul;38(4):40713.
18.Tollin M. Antimicrobial peptides & proteins in innate immunity: emphasis on
isolation, characterization and gene regulation [Doctoral thesis]. Sweden:
Karolinska Institutet; 2005.

19.

St I, I. Trebichavsk I. Calprotectin a pleiotropic molecule in acute and

chronic inflammation. Physiol Res. 2004;53: 245-53.

20.

Lusitani D, Malawista SE, Montgomery RR. Calprotectin, an abundant cytosolic

protein from human polymorphonuclear leukocytes, inhibits the growth of
Borrelia burgdorferi. Infect Immun. 2003 Aug; 71(8): 4711-6.

21.

Yoshio H, Tollin M, Gudmundsson GH, Lagercrantz H, Jrnvall H, Marchini G, et

al. Antimicrobial polypeptides of human vernix caseosa and amniotic fluid:
implications for newborn innate defense. Pediatr Res 2003;53:211-6.

22.

Yui S, Nakatani Y, Mikami M. Calprotectin (S100A8/S100A9), an inflammatory

protein complex from neutrophils with a broad apoptosis-inducing activity. Biol
Pharm Bull. 2003;26(6):753-60.

23.Vandal K, Rouleau P, Boivin A, Ryckman C, Talbot M, Tessier PA. Blockade of

S100A8 and S100A9 suppresses neutrophil migration in response to
lipopolysaccharide. J Immunol 2003;171:2602-9.
24.plchal I, Trebichavsk I, plchalov A, Dttov L, Zahradnkov M.
Escherichia coli administered into pig amniotic cavity appear in fetal airways and
attract macrophages into fetal lungs. Physiol Res. 2002;51:523-8.
25.Sampson B, Fagerhol MK, Sunderktter C, Golden BE, Richmond P, Klein N.
Hyperzincaemia and hypercalprotectinaemia: a new disorder of zincmetabolism.
Lancet 2002;360:1742-45.
26.Yui S, Nakatani Y, Hunter MJ, Chazin WJ, Yamazaki M. Implication of extracellular
zinc exclusion by recombinant human calprotectin (MRP8 and MRP14) from
target cells in its apoptosis-inducing activity. Mediators of Inflammation
2002;11:165-72.

27.

Nisapakultorn K, Ross KF, Herzberg MC. Calprotectin expression inhibits

bacterial binding to mucosal epithelial cells. Infect Immun. 2001; 69(6): 3692-6.

28.Hetland G, Talg GJ, Fagerhol MK. Chemotaxins C5a and fMLP induce release of
calprotectin (leucocyte L1 protein) from polymorphonuclear cells in vitro. J Clin
Pathol: Mol Pathol 1998;51:143-8.
29.Johne B, Fagerhol MK, Lyberg T, Prydz H, Brandtzag P, Naess-Andresen CF, Dale
I. Functional and clinical aspects of the myelomonocyte protein calprotectin. J
Clin Pathol:Mol Pathol 1997;50:113-23.